Biotech Stocks
Biotech filings and news · newest 2:30 PM ET · How scores work
Sun, Oct 112 events
8BBIOBridgeBio Pharma, Inc.Acoramidis Cuts Hospitalizations 27% vs Tafamidis in Largest EHR Study8BBIOBridgeBio Pharma, Inc.Encaleret Phase 3 Data Show 100% Symptom Improvement in ADH1; RECLAIM-HP Doses First Patient
Fri, Oct 918 events
7VTGNVistagen Therapeutics, Inc.Vistagen Expands Executive Severance Plan to Cover Terminations Without Change in Control8ARTLARTELO BIOSCIENCES, INC.Artelo Flags Nasdaq $5M MVLS Delisting Risk, Weighs More Dilutive Financing7MBRXMoleculin Biotech, Inc.Moleculin Stockholders Approve Reverse Split Authority and 3.86M Share Plan Expansion7CLGNCollPlant Biotechnologies LtdCollPlant Secures $3.7M Private Placement to Advance LightSolver Supercomputing7PYXSPyxis Oncology, Inc.Pyxis Oncology Seeks Approval to Double Authorized Shares to 380M to Cover Warrant Exercises8JSPRJasper Therapeutics, Inc.Jasper Seeks Approval to Convert 604M Preferred Shares — 95% Dilution for Existing Holders8PCVXVaxcyte, Inc.Vaxcyte Closes Upsized $1.1B Concurrent Offerings After Full Over-Allotment Exercise9TCRTAlaunos Therapeutics, Inc.Nasdaq Moves to Delist Alaunos Therapeutics Over Equity Shortfall9BGMSBio Green Med Solution, Inc.BGMS Mails Definitive Proxy for $2B Reverse Merger with Future NRG — Vote Set for Nov 197PCSAProcessa Pharmaceuticals, Inc.Processa Seeks Reverse Split Approval to Meet Nasdaq $4.00 Listing Requirement7PCSAProcessa Pharmaceuticals, Inc.Processa Registers 306.6M Shares for Resale by PIPE and Merger Investors8LNAILunai Bioworks Inc.Lunai Bioworks Requests Nasdaq Trading Suspension Amid Alleged Short-Selling Abuses7MLYSMineralys Therapeutics, Inc.Lorundrostat Hits 46% SBP Control in Resistant Hypertension, Expands OSA Data7ATOSAtossa Therapeutics, Inc.Atossa Executes CVR Deal: Shareholders Get 25% of Priority Review Voucher Proceeds7QNCXQuince Therapeutics, Inc.Quince Therapeutics Names Brigette Roberts CEO Amid Restructuring8QNCXQuince Therapeutics, Inc.Quince Therapeutics Rebrands as IRulya Therapeutics with New Leadership and $116M Cash Runway Through 20287SPTXSeaport Therapeutics, Inc.GlyphAgo Phase 1 PK Shows 6.8x Bioavailability, 10x Lower Variability7ALMSALUMIS INC.Envudeucitinib Shows Rapid, Durable Relief Across Scalp, Itch, and Quality of Life in Phase 3
Thu, Oct 820 events
8PHVSPharvaris N.V.Pharvaris' Deucrictibant Phase 3 Data Published in The Lancet, Showing Rapid HAE Attack Resolution8PPCBPropanc Biopharma, Inc.Propanc Biopharma Approves Reverse Stock Split to Preserve Nasdaq Listing7NWBONorthwest Biotherapeutics IncNW Bio Partners with UK NHS Blood and Transplant to Scale DCVax-L Production8FBLGFibroBiologics, Inc.FibroBiologics Sells $1.2M Convertible Debenture at 15% Discount to Peak One8FULCFulcrum Therapeutics, Inc.Fulcrum S-4 Amendment Adds HSR Clearance and Slate Phase 1 Trial Launch to Reverse Merger8PASGPassage BIO, Inc.Passage Bio Sets Nov 5 Vote on Remix Merger; Net Cash Estimate Rises to $10.9M8PCVXVaxcyte, Inc.Vaxcyte Finalizes $500M Equity Offering at $64/Share Alongside $500M Convertible Notes9JAGXJaguar Health, Inc.Jaguar Health Seeks Approval for Up to 92.9% Dilution, Reverse Split, and ELOC Floor Price Cut7TENXTenax Therapeutics, Inc.Tenax Pauses LEVEL-2 Enrollment to Amend Protocol After LEVEL Data7QSIQuantum-Si IncProteus Platform Reaches 19 Amino Acids, Closing In on Full 20-Amino-Acid Detection8TRAWTraws Pharma, Inc.Traws Pharma Seeks Stockholder Approval for 1-for-8 to 1-for-15 Reverse Split to Regain Nasdaq Compliance7LTRNLantern Pharma Inc.Lantern Pharma Seeks Approval to Double Authorized Shares and Issue 3.67M Warrant Shares7QSIQuantum-Si IncQuantum-Si's Proteus Hits 19 Amino Acids, Targets All 20 by Year-End9BOLDBoundless Bio, Inc.Boundless Bio Files S-4 for Reverse Merger with Serapha Bio: 96.2% Dilution, $44-48M Dividend, and Beam Litigation Risk7XRTXXORTX Therapeutics Inc.XORTX Adds Health Canada CTA Filing to Gout Program, Accelerating Global Regulatory Push7TVGNTevogen Inc.Tevogen Signs LOI to Explore HRK Healthcare Acquisition, Eyes $100M Revenue7ADCTADC Therapeutics SAADC Therapeutics Unveils Strategic Financial Restructuring to Strengthen Capital Structure7VIRVir Biotechnology, Inc.FDA Grants Fast Track to Vir's VIR-5500 for Late-Line Prostate Cancer7SRRKScholar Rock Holding CorpScholar Rock Resubmits Apitegromab MAA to EMA, Eyes CHMP Opinion in H1 20278AGENAgenus Inc.Armenia Grants First-Ever Marketing Authorizations for Agenus' BOT+BAL in MSS Colorectal Cancer
Biotech companies on Wiseek (606)
Each company page tracks that company's SEC filings, news and market data.
AAPGAARDABCLABEOABOSABSIABUSABVCABVXACADACETACHVACIUACLXACOGACRVACTUACXPADAGADCTADILADMAADPTADTXADXNAGENAGIOAGMBAIXCAKBAAKTSAKTXALDXALECALGSALLOALLRALMSALNYALTALXOALZNAMLXANABANIXANLANNXANROANTXANVSAPGEAPLMAPLSAPMAPREAPVOARCTARDXARGXARQTARTLARTVARVNARWRASBPASMBASNDATAIATHEATOSATRAATXIATYRAUPHAURAAUTLAVBPAVIRAVLNAVTXAVXLAXSMBBIOBBOTBCABBCAXBCDABCLIBCRXBCTXBCYCBDRXBDTXBEAMBGMSBHVNBIVIBLRXBLTEBMEABMRNBNTCBNTXBOLDBOLTBRNSBRTXBTAIBYSICABACADLCALCCAMPCAPRCBIOCBUSCCCCCDIOCDTCDXSCELCCELUCELZCGEMCGENCGONCGTXCHRSCINGCLDXCLGNCLLSCLNNCLRBCLYMCMMBCMNDCMPXCNSPCNTACNTBCNTNCNTXCOAGCOCPCOGTCORTCOYACPRXCRBPCRBUCRDFCRISCRMDCRNXCRSPCRVOCRVSCSBRCTMXCTNMCTXRCUECURXCVKDCYCNCYPHCYTKDAREDAWNDBVTDCOYDFTXDMACDMRADNADNLIDNTHDOMHDRMADRTSDRUGDSGNDTILDWTXDYAIDYNEDITEDSAEIKNELABELDNELOXELTXELVNEMMAENGNENLVENSCENTAENTXENVBENZNENZNDEPRXEQERASERNAESLAEVAXEVFMEVGNEVMNEWTXEXELEXOZEYPTFATFATEFBIOFBLGFBRXFDMTFENCFHTXFLNAFOLDFRMMFTREFULCGALTGANXGDTCGENBGERNGHRSGLMDGLPGGLSIGLUEGMABGNLXGNPXGNTAGOSSGOVXGPCRGRCEGRDXGRIGRMLGRTXGTBPGUTSGYREHALOHCWBHELPHOTHHOWLHRMYHRTXHUMAHURAHYFTHYPDIBIOIBRXICCCICUIDYAIFRXIKTIMAIMCRIMMPIMMXIMNMIMNNIMRNIMRXIMTXIMUXIMVTINABINBXINCYINDPINKTINMINMBINOINSMINTSINVAIONSIOVAIPHAIPSCIRDIRONIVAIVVDJAGXJANXJAZZJBIOJSPRJUNSKALVKLRAKNSAKODKPRXKPTIKROSKRROKRYSKTTAKURAKYMRKYNBKYTXKZIAKZRLABTLBRXLEGNLENZLEXXLGNDLGVNLIMNLITSLIXTLNAILONALPCNLQDALRMRLSTALTRNLXEOLXRXLYELLYRAMANEMAZEMBIOMBRXMBXMCRBMDGLMDWDMDXGMENSMESOMGNXMGTXMGXMIRMMISTMITIMLECMLTXMLYSMNKDMNOVMNPRMOLNMPLTMREOMRKRMRNAMRVIMSLEMTVANAGENAMSNAUTNBPNBTXNCELNCNANERVNEUPNGENNGNENKTRNKTXNMRANRIXNRSNNRXPNTHINTLANTRBNUVBNUVLNVAXNVCTNVONWBONXTCOABIOBIOOCGNOCSOCULODTXOKUROKYOOLMAOMERONCONCOONCYORGSORICORKAORMPOSRHOTLCOTLKOVIDPALIPASGPBMPBYIPCSAPCVXPDSBPEPGPGENPHARPHATPHIOPHVSPLRXPLRZPLURPLYXPMCBPMNPMVPPPBTPPCBPRAXPRLDPRMEPROKPRQRPRTAPRTCPSTVPTCTPTGXPTIXPULMPVCTPVLAPYPDPYXSQCLSQNCXQNRXQSIQTTBQURERADXRANIRAPPRARERCKTRCUSREGNREPLREVBRGNXRIGLRLAYRLMDRLYBRNARNACRNAZRNTXRNXTROIVRPRXRVMDRVPHRXRXRYTMRZLTSABSSANASCNISEERSEPNSGMOSGMTSILOSIONSKYESLDBSLGLSLNSLNOSLSSLXNSMMTSNDXSNGXSNSESNTISPRBSPRCSPROSPRYSPTXSRPTSRRKSRZNSTOKSTROSTTKSVRASXTPSYBXSYRETAOXTARATARSTBPHTCRTTCRXTECHTECXTELOTENXTERNTGTXTILTLSATLXTNGXTNXPTNYATPSTTRAWTRDATRVITSHATTRXTVGNTVRDTVTXTYRAUNCYUPBURGNUTHRVALNVANIVCELVCYTVERAVERUVIRVIVSVKTXVNDAVORVRAXVRCAVRDNVRTXVSTMVTGNVTVTVXRTVYGRVYNEWHWKWVEXBIOXBITXCURXENEXERSXFORXLOXNCRXOMAXRTXXTLBYDESZBIOZIVOZLABZNTLZSQRZURAZVRAZYME
How Wiseek picks and scores these
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a biotech company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
See the full Healthcare sector feed.